U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Vital Pharmaceuticals, Inc. dba VPX Sports - 04/03/2017
  1. Warning Letters


Vital Pharmaceuticals, Inc. dba VPX Sports

Vital Pharmaceuticals, Inc. dba VPX Sports

United States

Issuing Office:

United States



Black HHS-Blue FDA Logo



5001 Campus Drive
College Park, MD 20740

APRIL 3, 2017

Jack Owoc
Vital Pharmaceuticals
1600 North Park Drive
Weston, FL 33326

Dear Mr. Owoc:

The Food and Drug Administration (FDA) has completed an evaluation ofyour firm's corrective actions in response to our Warning Letter 446357, issued April 24, 2015. Based on our evaluation, it appears you have addressed the violations contained in the W aming Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Latasha A. Robinson
Branch Chief
Dietary Supplement and Labeling
     Assessment Branch
Division of Enforcement
Office of Compliance
Center for Food Safety and Applied

Marc J. Kesten
General Counsel

Back to Top